Summary
This business focuses on developing innovative immunology solutions aimed at improving the lives of patients with severe autoimmune diseases. It operates by creating a collaborative ecosystem that brings together scientists and antibody engineers to accelerate the discovery of novel therapeutic antibodies. The company emphasizes the importance of co-creation and partnership in its research and development efforts, with a proprietary portfolio of first-in-class product candidates designed to address unmet medical needs.